ArticleJAMA neurology2020

Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis.

Magí Andorrà et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.